Explore clinical studies
Study status and locations reflect public registry information as of October 21, 2026, not guaranteed appointment or enrollment availability.
Registry: recruitingPhase 3NCT07282600
Adults with obesity or overweight and type 2 diabetes; the study evaluates weight reduction with investigational eloralintide.
- Research area
- Obesity and type 2 diabetes
Basic study criteria: Age 18+; type 2 diabetes; BMI ≥27; stable diabetes treatment.
Selected registry-listed research locations
- Tucson Clinical Research Institute — Tucson, AZ
- San Fernando Valley Health Institute — Canoga Park, CA
- AMCR Institute — Escondido, CA
- NorCal Medical Research, Inc — Greenbrae, CA
Plus 9 more locations in this directory. Site recruitment may change.
Registry: recruitingPhase 3NCT07321886
Adults with obesity or overweight without type 2 diabetes; study compares investigational eloralintide with placebo.
- Research area
- Obesity without type 2 diabetes
Basic study criteria: Age 18+; BMI ≥30, or ≥27 plus a weight-related condition; people with type 2 diabetes excluded.
Selected registry-listed research locations
- Headlands Research - Scottsdale — Scottsdale, AZ
- Neighborhood Healthcare Institute of Health — Escondido, CA
- Ark Clinical Research - Fountain Valley — Fountain Valley, CA
- Desert Oasis Healthcare Medical Group — Palm Springs, CA
Plus 5 more locations in this directory. Site recruitment may change.
Registry: recruitingPhase 3NCT07351045
Study evaluates investigational enicepatide for weight management in adults without type 2 diabetes.
- Research area
- Obesity without type 2 diabetes
Basic study criteria: Age 18+; BMI ≥30, or ≥27 with a weight-related condition; diabetes excluded.
Selected registry-listed research locations
- Arizona Clinical Trials — Tucson, AZ
- University of California Irvine — Irvine, CA
- Artemis Institute for Clinical Research, LLC — San Diego, CA
- Diablo Clinical Research, Inc. — Walnut Creek, CA
Plus 2 more locations in this directory. Site recruitment may change.
Registry: recruitingPhase 3NCT07351058
Study evaluates investigational enicepatide for weight management among adults living with type 2 diabetes.
- Research area
- Obesity and type 2 diabetes
Basic study criteria: Age 18+; BMI ≥27; type 2 diabetes with specified HbA1c and stable treatment.
Selected registry-listed research locations
- Arizona Clinical Trials — Tucson, AZ
- University of California Irvine — Irvine, CA
- Orange County Research Center — Lake Forest, CA
- Ark Clinical Research — Long Beach, CA
Plus 4 more locations in this directory. Site recruitment may change.
Registry: recruitingPhase 2NCT07589608
Study investigates two investigational medicines, separately or together, in adults with obesity or overweight without type 2 diabetes.
- Research area
- Obesity without type 2 diabetes
Basic study criteria: Ages 18–75; no type 1 or type 2 diabetes; additional master protocol criteria.
Selected registry-listed research locations
- Arizona Clinical Trials - Mesa — Chandler, AZ
- Headlands Research - Scottsdale — Scottsdale, AZ
- Arizona Liver Health - Tucson — Tucson, AZ
- NorCal Medical Research, Inc — Greenbrae, CA
Plus 3 more locations in this directory. Site recruitment may change.
Registry: recruitingPhase 3NCT07575399
Study evaluates switching from a weekly GLP-1 medicine to investigational maridebart cafraglutide in adults with obesity or overweight.
- Research area
- Obesity without type 2 diabetes
Basic study criteria: Age 18+; already using a stable weekly GLP-1 medicine with prior weight loss; diabetes excluded.
Selected registry-listed research locations
- Arizona Clinical Trials — Chandler, AZ
- Epic Medical Research - Sun City — Sun City, AZ
- Clinical Research Institute of Arizona LLC — Sun City West, AZ
- Desert Oasis Healthcare Medical Group — Palm Springs, CA
Plus 5 more locations in this directory. Site recruitment may change.
Registry: recruitingPhase 3NCT07770841
Study compares investigational lower oral semaglutide doses with placebo for weight management.
- Research area
- Obesity without type 2 diabetes
Basic study criteria: Age 18+; BMI ≥30, or ≥27 with a weight-related condition; additional lab and medication restrictions.
Selected registry-listed research locations
- Headlands Research California, LLC — Escondido, CA
- National Research Institute - Huntington Park — Huntington Park, CA
- Los Angeles Institute for Metabolic Research — Los Angeles, CA
- East West Med Res Inst — Honolulu, HI
Site recruitment may change.
Registry: recruitingPhase 3NCT07817251
Study examines safety and tolerability when adults with type 2 diabetes switch from semaglutide to investigational CagriSema.
- Research area
- Type 2 diabetes
Basic study criteria: Age 18+; type 2 diabetes; currently on relevant semaglutide treatment; study team determines fit.
Selected registry-listed research locations
- Gilbert Center For Family Medicine — Gilbert, AZ
- Ark Clinical Research — Fountain Valley, CA
- Thrive Clinical Research Group — Glendora, CA
- Scripps Whittier Diabetes Inst — La Jolla, CA
Plus 9 more locations in this directory. Site recruitment may change.
Registry: active, not recruitingPhase 3NCT07284875
Adults with obesity, or overweight with a weight-related condition, without diabetes; the study compares investigational ribupatide with placebo.
- Research area
- Obesity without type 2 diabetes
Basic study criteria: Age 18+; BMI ≥30, or ≥27 with a weight-related condition; diabetes excluded.
Selected registry-listed research locations
- Kailera clinical site (name not disclosed) — Sun City, AZ
- Kailera clinical site (name not disclosed) — Escondido, CA
- Kailera clinical site (name not disclosed) — Toluca Lake, CA
- Kailera clinical site (name not disclosed) — Salt Lake City, UT
Not enrolling new participants.
Registry: active, not recruitingPhase 3NCT07284979
Adults with obesity without diabetes; the study compares investigational ribupatide with semaglutide and with placebo.
- Research area
- Obesity without type 2 diabetes
Basic study criteria: Age 18+; BMI ≥35; diabetes excluded.
Selected registry-listed research locations
- Kailera clinical site (name not disclosed) — Glendale, AZ
- Kailera clinical site (name not disclosed) — Phoenix, AZ
- Kailera clinical site (name not disclosed) — Northridge, CA
- Kailera clinical site (name not disclosed) — Oceanside, CA
Not enrolling new participants.